Showing results (2011-2020 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|July 16, 2003
The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature reviewManishi Prasad, Anne M Rentz, Dennis A RevickiPharmacoeconomics|July 16, 2003
Can sequential administration minimise the cost of high dose chemotherapy? An economic assessment in inflammatory breast cancerPatricia Marino, Anne-Gaelle Le Corroller, Thao Palangié, et al.Pharmacoeconomics|September 10, 2003
The incorporation of potential confounding variables in Markov modelsMark J C Nuijten, Frans RuttenPharmacoeconomics|June 28, 2003
Consumer preference for dinoprostone vaginal gel using stated preference discrete choice modellingSusan Taylor, Carol ArmourPharmacoeconomics|June 28, 2003
Lower respiratory tract infections: impact on the workplaceHoward Birnbaum, Melissa Morley, Stephanie Leong, et al.Pharmacoeconomics|March 22, 2003
A pharmacoeconomic evaluation of the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study in the United KingdomNigel Buller, David Gillen, Roman Casciano, et al.Pharmacoeconomics|March 22, 2003
Financial and health costs of uncontrolled blood pressure in the United KingdomAdam Lloyd, Claudia Schmieder, Nick MarchantPharmacoeconomics|November 5, 2003
Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in FranceMarie de Zelicourt, Roland Dardennes, Hélène Verdoux, et al.Pharmacoeconomics|November 5, 2003
Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of diseaseRoger Jones, Silke Horbach, Peter Sander, et al.Pharmacoeconomics|February 12, 2004
Cost effectiveness of interventions for lateral epicondylitis: results from a randomised controlled trial in primary careIngeborg B C Korthals-de Bos, Nynke Smidt, Maurits W van Tulder, et al.Pageof 336